Pearce Samantha insider trades
Pearce Samantha has filed 25 Form 4s with the SEC that we hold, all for Jazz Pharmaceuticals plc (JAZZ), as EVP, Chief Commercial Officer. Across all of them we count 0 purchases worth $0 and 12 sales worth $4.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($1.6M). The largest single trade was a sale of 6,907 shares of Jazz Pharmaceuticals plc worth $1.6M, dated 2026-05-28. The first filing on our record is dated 2022-03-09 and the latest 2026-08-07.
Jazz Pharmaceuticals plc (JAZZ)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-06-08 | S, sale reported on Form 4 | 2,652 | $411.1K | 2022-06-10 |
| 2022-06-08 | S, sale reported on Form 4 | 5,835 | $904.4K | 2022-06-10 |
| 2022-06-27 | S, sale reported on Form 4 | 8,508 | $1.3M | 2022-06-29 |
| 2022-07-12 | S, sale reported on Form 4 | 532 | $82.5K | 2022-07-14 |
| 2022-08-04 | S, sale reported on Form 4 | 531 | $82.3K | 2022-08-08 |
| 2022-09-02 | S, sale reported on Form 4 | 531 | $83.4K | 2022-09-07 |
| 2022-11-10 | S, sale reported on Form 4 | 532 | $82.5K | 2022-11-14 |
| 2022-11-10 | S, sale reported on Form 4 | 531 | $82.3K | 2022-11-14 |
| 2022-12-13 | S, sale reported on Form 4 | 531 | $82.5K | 2022-12-15 |
| 2023-01-03 | S, sale reported on Form 4 | 531 | $84.7K | 2023-01-05 |
| 2023-02-02 | S, sale reported on Form 4 | 531 | $83.5K | 2023-02-06 |
| 2026-05-28 | S, sale reported on Form 4 | 6,907 | $1.6M | 2026-06-01 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1805688) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms